TAIPEI, 14. November 2025 /PRNewswire/ -- EirGenix Inc.(TWSE: 6589) gab am 12. November den Abschluss eines zweiten globalen Exklusivlizenzvertrags mit dem internationalen Marktführer für Biosimilars, der Sandoz AG (SIX:SDZ/OTCQX:SDZNY), für die Vermarktung seines eigenständig...
Hence then, the article about eirgenix unterzeichnete die kommerzielle lizenzvereinbarung fur sein zweites her2 biosimilar eg1206a was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( EirGenix unterzeichnete die kommerzielle Lizenzvereinbarung für sein zweites HER2-Biosimilar EG1206A )
Also on site :
- Taking an omega-3 supplement may not boost memory or cognition
- Julia Fox’s Video of Her Son Trying To Give Donuts to the NYPD at the Knicks Parade Will Make Your Day
- KFC Rival Opens First-of-Its-Kind Restaurant Complete With 24-Hour Service